Tapewire

NYSE · USD

ELV

Elevance Health, Inc.

Export transactions ↓
Tapewire entity
2934
SEC CIK
0001156039
Parsed reports
385

Last 12 months

Inside the activity.

4 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202612
Apr 202600
May 202601
Jun 202602
Jul 202630
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 03, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 653 $0.00 Strike: $271.27 $0.00
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · derivative · entry 11

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 654

Underlying: Common Stock · 653 shares

Expires 2030-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option represents a right to purchase a total of 1,960 shares, and is exercisable in three annual installments, with two installments of 653 shares each and one installment of 654 shares, beginning on 3/2/2021, which is the one-year anniversary of the option grant date.

Read SEC document
March 03, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 438 $0.00 Strike: $311.48 $0.00
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · derivative · entry 10

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 877

Underlying: Common Stock · 438 shares

Expires 2031-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option represents a right to purchase a total of 1,315 shares, and is exercisable in three annual installments, with two installments of 438 shares each and one installment of 439 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.

Read SEC document
March 03, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
SaleCommon Stock 2,423 $463.68 $1,123,496.64
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 8

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,902

F4 · price: This transaction was executed in multiple trades at prices ranging from $463.57 to $463.73. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionCommon Stock 468 $307.68 $143,994.24
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 7

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionCommon Stock 653 $271.27 $177,139.31
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 6

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionCommon Stock 438 $311.48 $136,428.24
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 5

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
Tax withholdingCommon Stock 52 $463.49 $24,101.48
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 4

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,766

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 21:45 UTC
Gallina John EEVP & Chief Financial Officer
GiftCommon Stock 1,420 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 5

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,181

Read SEC document
March 02, 2022 Filed Mar 3, 2022 21:45 UTC
Gallina John EEVP & Chief Financial Officer
Tax withholdingCommon Stock 413 $463.49 $191,421.37
Disclosure

SEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 4

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,601

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 21:44 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
Tax withholdingCommon Stock 487 $463.49 $225,719.63
Disclosure

SEC source: 0001156039-22-000023 · wf-form4_164634386593932.xml · nonDerivative · entry 4

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,731

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 21:44 UTC
Kendrick Charles Morgan JREVP & President, Commercial
Tax withholdingCommon Stock 110 $463.49 $50,983.90
Disclosure

SEC source: 0001156039-22-000022 · wf-form4_164634380821770.xml · nonDerivative · entry 4

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,529

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 21:43 UTC
Haytaian Peter DEVP & Pres., DBG & IngenioRx
Tax withholdingCommon Stock 493 $463.49 $228,500.57
Disclosure

SEC source: 0001156039-22-000021 · wf-form4_164634376392611.xml · nonDerivative · entry 4

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,016

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 21:42 UTC
Norwood Felicia FEVP & President, GBD
Tax withholdingCommon Stock 446 $463.49 $206,716.54
Disclosure

SEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 4

Norwood Felicia F · CIK 0001743548 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,438

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 21:41 UTC
BOUDREAUX GAILDirector · President and CEO
Tax withholdingCommon Stock 1,645 $463.49 $762,441.05
Disclosure

SEC source: 0001156039-22-000018 · wf-form4_164634367676049.xml · nonDerivative · entry 4

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,639

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

F4 · balance_after: Balance includes 226.50 shares acquired on March 25, 2021, 213.43 shares acquired on June 25, 2021, 214.36 shares acquired on September 24, 2021 and 184.20 shares acquired on December 21, 2021 through a dividend reinvestment plan.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
GrantEmployee Stock Option (Right to Buy) · Derivative 882 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · derivative · entry 9

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 882

Underlying: Common Stock · 882 shares

Expires 2032-03-01

F5 · derivative.exercise_date: The option represents a right to purchase a total of 882 shares, and is exercisable in three annual installments of 294 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
GrantCommon Stock 953 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 3

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,818

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
GrantCommon Stock 222 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 2

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,865

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 74 shares each on 3/1/2023, 3/1/2024 and 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:06 UTC
Penczek Ronald WCAO & Controller
Tax withholdingCommon Stock 369 $451.50 $166,603.50
Disclosure

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · nonDerivative · entry 1

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,643

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:45 UTC
Gallina John EEVP & Chief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 11,594 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · derivative · entry 6

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,594

Underlying: Common Stock · 11,594 shares

Expires 2032-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,594 shares, and is exercisable in three annual installments, with one installment of 3,864 shares and two installments of 3,865 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:45 UTC
Gallina John EEVP & Chief Financial Officer
GrantCommon Stock 8,250 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 3

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,014

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:45 UTC
Gallina John EEVP & Chief Financial Officer
GrantCommon Stock 2,907 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 2

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,764

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 969 shares each on 3/1/2023, 3/1/2024 and 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:45 UTC
Gallina John EEVP & Chief Financial Officer
Tax withholdingCommon Stock 4,162 $451.50 $1,879,143.00
Disclosure

SEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 1

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,857

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
GrantEmployee Stock Option (Right to Buy) · Derivative 8,832 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000023 · wf-form4_164634386593932.xml · derivative · entry 5

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,832

Underlying: Common Stock · 8,832 shares

Expires 2032-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,832 shares, and is exercisable in three annual installments of 2,944 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
GrantCommon Stock 8,250 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000023 · wf-form4_164634386593932.xml · nonDerivative · entry 3

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,218

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
GrantCommon Stock 2,215 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000023 · wf-form4_164634386593932.xml · nonDerivative · entry 2

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,968

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 738 shares each on 3/1/2023 and 3/1/2024, and 739 shares on 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
Tax withholdingCommon Stock 4,871 $451.50 $2,199,256.50
Disclosure

SEC source: 0001156039-22-000023 · wf-form4_164634386593932.xml · nonDerivative · entry 1

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,753

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
Kendrick Charles Morgan JREVP & President, Commercial
GrantEmployee Stock Option (Right to Buy) · Derivative 7,729 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000022 · wf-form4_164634380821770.xml · derivative · entry 5

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,729

Underlying: Common Stock · 7,729 shares

Expires 2032-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 7,729 shares, and is exercisable in three annual installments, with two installments of 2,576 shares each and one installment of 2,577 shares, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
Kendrick Charles Morgan JREVP & President, Commercial
GrantCommon Stock 2,031 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000022 · wf-form4_164634380821770.xml · nonDerivative · entry 3

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,639

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
Kendrick Charles Morgan JREVP & President, Commercial
GrantCommon Stock 1,938 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000022 · wf-form4_164634380821770.xml · nonDerivative · entry 2

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,608

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 646 shares each on 3/1/2023, 3/1/2024 and 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:44 UTC
Kendrick Charles Morgan JREVP & President, Commercial
Tax withholdingCommon Stock 804 $451.50 $363,006.00
Disclosure

SEC source: 0001156039-22-000022 · wf-form4_164634380821770.xml · nonDerivative · entry 1

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,670

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:43 UTC
Haytaian Peter DEVP & Pres., DBG & IngenioRx
GrantEmployee Stock Option (Right to Buy) · Derivative 8,832 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000021 · wf-form4_164634376392611.xml · derivative · entry 5

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,832

Underlying: Common Stock · 8,832 shares

Expires 2032-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,832 shares, and is exercisable in three annual installments of 2,944 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:43 UTC
Haytaian Peter DEVP & Pres., DBG & IngenioRx
GrantCommon Stock 8,250 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000021 · wf-form4_164634376392611.xml · nonDerivative · entry 3

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,509

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:43 UTC
Haytaian Peter DEVP & Pres., DBG & IngenioRx
GrantCommon Stock 2,215 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000021 · wf-form4_164634376392611.xml · nonDerivative · entry 2

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,259

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 738 shares each on 3/1/2023 and 3/1/2024, and 739 shares on 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:43 UTC
Haytaian Peter DEVP & Pres., DBG & IngenioRx
Tax withholdingCommon Stock 4,667 $451.50 $2,107,150.50
Disclosure

SEC source: 0001156039-22-000021 · wf-form4_164634376392611.xml · nonDerivative · entry 1

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,044

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:42 UTC
Todt Blair WilliamsEVP and Chief Legal Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 7,508 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000020 · wf-form4_164634373268882.xml · derivative · entry 3

Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,508

Underlying: Common Stock · 7,508 shares

Expires 2032-03-01

F3 · derivative.exercise_date: The option represents a right to purchase a total of 7,508 shares, and is exercisable in three annual installments, with one installment of 2,502 shares and two installments of 2,503 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:42 UTC
Todt Blair WilliamsEVP and Chief Legal Officer
GrantCommon Stock 1,883 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000020 · wf-form4_164634373268882.xml · nonDerivative · entry 2

Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,417

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 627 shares on 3/1/2023, and 628 shares each on 3/1/2024 and 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:42 UTC
Todt Blair WilliamsEVP and Chief Legal Officer
Tax withholdingCommon Stock 191 $451.50 $86,236.50
Disclosure

SEC source: 0001156039-22-000020 · wf-form4_164634373268882.xml · nonDerivative · entry 1

Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,534

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:42 UTC
Norwood Felicia FEVP & President, GBD
GrantEmployee Stock Option (Right to Buy) · Derivative 8,832 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · derivative · entry 5

Norwood Felicia F · CIK 0001743548 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,832

Underlying: Common Stock · 8,832 shares

Expires 2032-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,832 shares, and is exercisable in three annual installments of 2,944 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:42 UTC
Norwood Felicia FEVP & President, GBD
GrantCommon Stock 6,981 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 3

Norwood Felicia F · CIK 0001743548 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,884

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:42 UTC
Norwood Felicia FEVP & President, GBD
GrantCommon Stock 2,215 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 2

Norwood Felicia F · CIK 0001743548 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,903

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 738 shares each on 3/1/2023 and 3/1/2024, and 739 shares on 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:42 UTC
Norwood Felicia FEVP & President, GBD
Tax withholdingCommon Stock 3,568 $451.50 $1,610,952.00
Disclosure

SEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 1

Norwood Felicia F · CIK 0001743548 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,688

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:41 UTC
BOUDREAUX GAILDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 32,682 $0.00 Strike: $451.50 $0.00
Disclosure

SEC source: 0001156039-22-000018 · wf-form4_164634367676049.xml · derivative · entry 5

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,682

Underlying: Common Stock · 32,682 shares

Expires 2032-03-01

F5 · derivative.exercise_date: The option represents a right to purchase a total of 32,682 shares, and is exercisable in three annual installments of 10,894 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:41 UTC
BOUDREAUX GAILDirector · President and CEO
GrantCommon Stock 28,303 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000018 · wf-form4_164634367676049.xml · nonDerivative · entry 3

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,284

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:41 UTC
BOUDREAUX GAILDirector · President and CEO
GrantCommon Stock 8,195 $0.00 $0.00
Disclosure

SEC source: 0001156039-22-000018 · wf-form4_164634367676049.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,981

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 2,731 shares on 3/1/2023, and 2,732 shares each on 3/1/2024 and 3/1/2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:41 UTC
BOUDREAUX GAILDirector · President and CEO
Tax withholdingCommon Stock 15,352 $451.50 $6,931,428.00
Disclosure

SEC source: 0001156039-22-000018 · wf-form4_164634367676049.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,786

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:34 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 653 $0.00 Strike: $271.27 $0.00
Disclosure

SEC source: 0001156039-22-000006 · wf-form4_164435608164172.xml · derivative · entry 9

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,307

Underlying: Common Stock · 653 shares

Expires 2030-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option represents a right to purchase a total of 1,960 shares, and is exercisable in three annual installments, with two installments of 653 shares each and one installment of 654 shares, beginning on 3/2/2021, which is the one-year anniversary of the option grant date.

Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:34 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 357 $0.00 Strike: $166.97 $0.00
Disclosure

SEC source: 0001156039-22-000006 · wf-form4_164435608164172.xml · derivative · entry 8

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 357 shares

Expires 2027-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option represents a right to purchase a total of 2,141 shares, and is exercisable in six semi-annual installments, with one installment of 356 shares and five installments of 357 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.

Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:34 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 935 $0.00 Strike: $307.68 $0.00
Disclosure

SEC source: 0001156039-22-000006 · wf-form4_164435608164172.xml · derivative · entry 7

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468

Underlying: Common Stock · 935 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option represents a right to purchase a total of 1,403 shares, and is exercisable in three annual installments, with one installment of 467 shares and two installments of 468 shares each, beginning on 3/1/2020, which is the one-year anniversary of the option grant date.

Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:34 UTC
Penczek Ronald WCAO & Controller
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 818 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001156039-22-000006 · wf-form4_164435608164172.xml · derivative · entry 6

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 818 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option represents a right to purchase a total of 1,634 shares, and is exercisable in six semi-annual installments, with four installments of 272 shares each and two installments of 273 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:34 UTC
Penczek Ronald WCAO & Controller
SaleCommon Stock 2,763 $453.48 $1,252,965.24
Disclosure

SEC source: 0001156039-22-000006 · wf-form4_164435608164172.xml · nonDerivative · entry 5

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,012

F1 · balance_after: Balance includes 3.4072 shares acquired on December 21, 2021 through a dividend reinvestment plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.